{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:35:20Z","timestamp":1785407720380,"version":"3.56.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T00:00:00Z","timestamp":1705190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T00:00:00Z","timestamp":1705190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S005021\/1"],"award-info":[{"award-number":["MR\/S005021\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W019027\/1"],"award-info":[{"award-number":["MR\/W019027\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["PMDS22080748827"],"award-info":[{"award-number":["PMDS22080748827"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["121311"],"award-info":[{"award-number":["121311"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013372","name":"Wellcome Trust Centre for Mitochondrial Research","doi-asserted-by":"publisher","award":["203105\/Z\/16\/Z"],"award-info":[{"award-number":["203105\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/501100013372","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mitochondrial Disease Patient Cohort","award":["G0800674"],"award-info":[{"award-number":["G0800674"]}]},{"DOI":"10.13039\/501100022186","name":"Lily Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022186","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Biomedical Research Centre for Ageing and Age-related Disease"},{"DOI":"10.13039\/501100005274","name":"North-West University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005274","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Multiple acyl-CoA dehydrogenase deficiency (MADD) is an autosomal recessive disorder resulting from pathogenic variants in three distinct genes, with most of the variants occurring in the electron transfer flavoprotein-ubiquinone oxidoreductase gene (\n                      <jats:italic>ETFDH)<\/jats:italic>\n                      . Recent evidence of potential founder variants for MADD in the South African (SA) population, initiated this extensive investigation. As part of the International Centre for Genomic Medicine in Neuromuscular Diseases study, we recruited a cohort of patients diagnosed with MADD from academic medical centres across SA over a three-year period. The aim was to extensively profile the clinical, biochemical, and genomic characteristics of MADD in this understudied population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical evaluations and whole exome sequencing were conducted on each patient. Metabolic profiling was performed before and after treatment, where possible. The recessive inheritance and phase of the variants were established via segregation analyses using Sanger sequencing. Lastly, the haplotype and allele frequencies were determined for the two main variants in the four largest SA populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twelve unrelated families (ten of White SA and two of mixed ethnicity) with clinically heterogeneous presentations in 14 affected individuals were observed, and five pathogenic\n                      <jats:italic>ETFDH<\/jats:italic>\n                      variants were identified. Based on disease severity and treatment response, three distinct groups emerged. The most severe and fatal presentations were associated with the homozygous c.[1067G\u2009&gt;\u2009A];c.[1067G\u2009&gt;\u2009A] and compound heterozygous c.[976G\u2009&gt;\u2009C];c.[1067G\u2009&gt;\u2009A] genotypes, causing MADD types I and I\/II, respectively. These, along with three less severe compound heterozygous genotypes (c.[1067G\u2009&gt;\u2009A];c.[1448C\u2009&gt;\u2009T], c.[740G\u2009&gt;\u2009T];c.[1448C\u2009&gt;\u2009T], and c.[287dupA*];c.[1448C\u2009&gt;\u2009T]), resulting in MADD types II\/III, presented before the age of five years, depending on the time and maintenance of intervention. By contrast, the homozygous c.[1448C\u2009&gt;\u2009T];c.[1448C\u2009&gt;\u2009T] genotype, which causes MADD type III, presented later in life. Except for the type I, I\/II and II cases, urinary metabolic markers for MADD improved\/normalised following treatment with riboflavin and L-carnitine. Furthermore, genetic analyses of the most frequent variants (c.[1067G\u2009&gt;\u2009A] and c.[1448C\u2009&gt;\u2009T]) revealed a shared haplotype in the region of\n                      <jats:italic>ETFDH<\/jats:italic>\n                      , with SA population-specific allele frequencies of\u2009&lt;\u20090.00067\u20130.00084%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study reveals the first extensive genotype\u2013phenotype profile of a MADD patient cohort from the diverse and understudied SA population. The pathogenic variants and associated variable phenotypes were characterised, which will enable early screening, genetic counselling, and patient-specific treatment of MADD in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-023-03014-8","type":"journal-article","created":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T17:01:48Z","timestamp":1705251708000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical, biochemical, and genetic spectrum of MADD in a South African cohort: an ICGNMD study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0112-0691","authenticated-orcid":false,"given":"Michelle","family":"Bisschoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1091-5912","authenticated-orcid":false,"given":"Izelle","family":"Smuts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5152-4782","authenticated-orcid":false,"given":"Marli","family":"Dercksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6762-2232","authenticated-orcid":false,"given":"Maryke","family":"Schoonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2371-288X","authenticated-orcid":false,"given":"Barend C.","family":"Vorster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5197-568X","authenticated-orcid":false,"given":"George","family":"van der Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9638-2071","authenticated-orcid":false,"given":"Careni","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2302-4901","authenticated-orcid":false,"given":"Kireshnee","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4006-8101","authenticated-orcid":false,"given":"Franclo","family":"Henning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0612-2071","authenticated-orcid":false,"given":"Surita","family":"Meldau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8833-2688","authenticated-orcid":false,"given":"Robert","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6806-8675","authenticated-orcid":false,"given":"Krutik","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2568-8326","authenticated-orcid":false,"given":"Mahmoud R.","family":"Fassad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9508-0477","authenticated-orcid":false,"given":"Jana","family":"Vandrovcova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The ICGNMD Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7818-1452","authenticated-orcid":false,"given":"Ronald J. A.","family":"Wanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7879-1776","authenticated-orcid":false,"given":"Francois H.","family":"van der Westhuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,14]]},"reference":[{"key":"3014_CR1","unstructured":"Orphanet. Multiple acyl-CoA dehydrogenase deficiency (ORPHAcode:26791). https:\/\/www.orpha.net\/. Accessed 14 Apr 2023."},{"key":"3014_CR2","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1046\/j.1432-1033.2003.03946.x","volume":"271","author":"S Ghisla","year":"2004","unstructured":"Ghisla S, Thorpe C. Acyl-CoA dehydrogenases. A mechanistic overview. Eur J Biochem. 2004;271:494\u2013508.","journal-title":"Eur J Biochem"},{"key":"3014_CR3","doi-asserted-by":"publisher","first-page":"105899","DOI":"10.1016\/j.biocel.2020.105899","volume":"132","author":"M Mereis","year":"2021","unstructured":"Mereis M, Wanders RJA, Schoonen M, Dercksen M, Smuts I, van der Westhuizen FH. Disorders of flavin adenine dinucleotide metabolism: MADD and related deficiencies. Int J Biochem Cell Biol. 2021;132:105899.","journal-title":"Int J Biochem Cell Biol"},{"key":"3014_CR4","volume-title":"The online metabolic and molecular bases of inherited disease","author":"FE Frerman","year":"2004","unstructured":"Frerman FE, Goodman SI. Chapter 103: defects of electron transfer flavoprotein and electron transfer flavoprotein-ubiquinone oxidoreductase: glutaric academia type. In: Valle D, Beaudet AL, Vogelstein B, editors. The online metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2004."},{"key":"3014_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13023-014-0117-5","volume":"9","author":"SC Gr\u00fcnert","year":"2014","unstructured":"Gr\u00fcnert SC. Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme a dehydrogenase deficiency. Orphanet J Rare Dis. 2014;9:117.","journal-title":"Orphanet J Rare Dis"},{"key":"3014_CR6","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/jimd.12147","volume":"42","author":"WJ van Rijt","year":"2019","unstructured":"van Rijt WJ, Ferdinandusse S, Giannopoulos P, Ruiter JPN, de Boer L, Bosch AM, et al. Prediction of disease severity in multiple acyl-CoA dehydrogenase deficiency: a retrospective and laboratory cohort study. J Inherit Metab Dis. 2019;42:878\u201389.","journal-title":"J Inherit Metab Dis"},{"key":"3014_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pediatrneurol.2019.06.015","volume":"99","author":"Y Y\u0131ld\u0131z","year":"2019","unstructured":"Y\u0131ld\u0131z Y, Talim B, Haliloglu G, Topaloglu H, Ak\u00e7\u00f6ren Z, Dursun A, Tokatl\u0131 A. Determinants of riboflavin responsiveness in multiple Acyl-CoA dehydrogenase deficiency. Pediatr Neurol. 2019;99:69\u201375. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2019.06.015.","journal-title":"Pediatr Neurol"},{"key":"3014_CR8","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.3390\/ijms21113847","volume":"21","author":"S Mosegaard","year":"2020","unstructured":"Mosegaard S, Dipace G, Bross P, Carlsen J, Gregersen N, Olsen RKJ. Riboflavin deficiency-implications for general human health and inborn errors of metabolism. Int J Mol Sci. 2020;21:3847.","journal-title":"Int J Mol Sci"},{"key":"3014_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.braindev.2005.06.010","volume":"28","author":"N Gordon","year":"2006","unstructured":"Gordon N. Glutaric aciduria types I and II. Brain Dev. 2006;28:136\u201340.","journal-title":"Brain Dev"},{"key":"3014_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jns.2017.11.012","volume":"384","author":"FH van der Westhuizen","year":"2018","unstructured":"van der Westhuizen FH, Smuts I, Honey E, Louw R, Schoonen M, Jonck LM, et al. A novel mutation in ETFDH manifesting as severe neonatal-onset multiple acyl-CoA dehydrogenase deficiency. J Neurol Sci. 2018;384:121\u20135.","journal-title":"J Neurol Sci"},{"key":"3014_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201323.","journal-title":"Genet Med"},{"key":"3014_CR12","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.3390\/jcm10214855","volume":"10","author":"P Ruiz-Sala","year":"2021","unstructured":"Ruiz-Sala P, Pe\u00f1a-Quintana L. Biochemical markers for the diagnosis of mitochondrial fatty acid oxidation diseases. J Clin Med. 2021;10:4855.","journal-title":"J Clin Med"},{"key":"3014_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10545-013-9671-6","volume":"37","author":"J Xi","year":"2014","unstructured":"Xi J, Wen B, Lin J, Zhu W, Luo S, Zhao C, et al. Clinical features and ETFDH mutation spectrum in a cohort of 90 Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 2014;37:399\u2013404.","journal-title":"J Inherit Metab Dis"},{"key":"3014_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CM9.0000000000000032","volume":"132","author":"DJ Hong","year":"2019","unstructured":"Hong DJ, Zhu M, Zhu ZJ, Cong L, Zhong SS, Liu L, et al. Clinical and muscle magnetic resonance image findings in patients with late-onset multiple acyl-CoA dehydrogenase deficiency. Chin Med J (Engl). 2019;132:275\u201384.","journal-title":"Chin Med J (Engl)"},{"key":"3014_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1515\/jpem-2020-0694","volume":"34","author":"Y Lin","year":"2021","unstructured":"Lin Y, Zhang W, Chen Z, Lin C, Lin W, Fu Q, et al. Newborn screening and molecular features of patients with multiple acyl-CoA dehydrogenase deficiency in Quanzhou, China. J Pediatr Endocrinol Metab. 2021;34:649\u201352.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"3014_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1203\/00006450-198001000-00004","volume":"14","author":"SI Goodman","year":"1980","unstructured":"Goodman SI, McCabe ER, Fennessey PV, Mace JW. Multiple acyl-CoA dehydrogenase deficiency (glutaric aciduria type II) with transient hypersarcosinemia and sarcosinuria; possible inherited deficiency of an electron transfer flavoprotein. Pediatr Res. 1980;14(1):12\u20137.","journal-title":"Pediatr Res"},{"issue":"Pt 8","key":"3014_CR17","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/brain\/awm054","volume":"130","author":"K Gempel","year":"2007","unstructured":"Gempel K, Topaloglu H, Talim B, Schneiderat P, Schoser BG, Hans VH, et al. The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. Brain. 2007;130(Pt 8):2037\u201344.","journal-title":"Brain"},{"key":"3014_CR18","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1093\/hmg\/dds175","volume":"21","author":"N Cornelius","year":"2012","unstructured":"Cornelius N, Frerman FE, Corydon TJ, Palmfeldt J, Bross P, Gregersen N, et al. Molecular mechanisms of riboflavin responsiveness in patients with ETF-QO variations and multiple acyl-CoA dehydrogenation deficiency. Hum Mol Genet. 2012;21:3435\u201348.","journal-title":"Hum Mol Genet"},{"key":"3014_CR19","unstructured":"gnomAD. https:\/\/gnomad.broadinstitute.org\/. Accessed 14 Apr 2023."},{"key":"3014_CR20","unstructured":"H3Africa. https:\/\/agvd-dev.h3abionet.org. Accessed 14 Apr 2023."},{"issue":"Suppl 2","key":"3014_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/BF01811480","volume":"8","author":"C Erasmus","year":"1985","unstructured":"Erasmus C, Mienie LJ, Reinecke CJ, Wadman SK. Organic aciduria in late-onset biotin-responsive multiple carboxylase deficiency. J Inherit Metab Dis. 1985;8(Suppl 2):105\u20136.","journal-title":"J Inherit Metab Dis"},{"key":"3014_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s11306-011-0309-0","volume":"8","author":"CJ Reinecke","year":"2012","unstructured":"Reinecke CJ, Koekemoer G, van der Westhuizen FH, Louw R, Lindeque JZ, Mienie LJ, et al. Metabolomics of urinary organic acids in respiratory chain deficiencies in children. Metabolomics. 2012;8:264\u201383.","journal-title":"Metabolomics"},{"issue":"11","key":"3014_CR23","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1093\/clinchem\/48.11.1970","volume":"48","author":"JJ Pitt","year":"2002","unstructured":"Pitt JJ, Eggington M, Kahler SG. Comprehensive screening of urine samples for inborn errors of metabolism by electrospray tandem mass spectrometry. Clin Chem. 2002;48(11):1970\u201380.","journal-title":"Clin Chem"},{"issue":"9","key":"3014_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11306-021-01825-z","volume":"17","author":"A Swanepoel","year":"2021","unstructured":"Swanepoel A, Bester J, Kruger Y, Davoren E, du Preez I. The effect of combined oral contraceptives containing drospirenone and ethinylestradiol on serum levels of amino acids and acylcarnitines. Metabolomics. 2021;17(9):75.","journal-title":"Metabolomics"},{"key":"3014_CR25","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1093\/bioinformatics\/btq330","volume":"26","author":"W McLaren","year":"2010","unstructured":"McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics. 2010;26:2069\u201370.","journal-title":"Bioinformatics"},{"key":"3014_CR26","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s41588-019-0528-2","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin AR, Williams E, Foulger RE, Leigh S, Daugherty LC, Niblock O, et al. PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels. Nat Genet. 2019;51:1560\u20135.","journal-title":"Nat Genet"},{"key":"3014_CR27","unstructured":"PLINK. https:\/\/www.cog-genomics.org\/plink\/1.9. Accessed 1 June 2023."},{"key":"3014_CR28","unstructured":"Eagle. https:\/\/alkesgroup.broadinstitute.org\/Eagle\/. Accessed 1 June 2023."},{"key":"3014_CR29","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.1038\/s41467-020-19588-x","volume":"11","author":"J Nait Saada","year":"2020","unstructured":"Nait Saada J, Kalantzis G, Shyr D, Cooper F, Robinson M, Gusev A, Palamara PF. Identity-by-descent detection across 487,409 British samples reveals fine scale population structure and ultra-rare variant associations. Nat Commun. 2020;11:6130.","journal-title":"Nat Commun"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-03014-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-03014-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-03014-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T17:02:49Z","timestamp":1705251769000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-03014-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,14]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3014"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-03014-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3145586\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,14]]},"assertion":[{"value":"7 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patients in this study were enrolled as part of the ICGNMD study with ethical approval numbers 19\/LO\/1796 [Health Research Authority (HRA) and Health and Care Research Wales (HCRW)], NWU-00966-19-A1 and NWU-00966-19-A1-01 [Health Research Ethics Committee (NWU-HREC) of the Faculty of Health Sciences, North-West University], 296\/2019 (Faculty of Health Sciences Research Ethics Committee, University of Pretoria), B19\/01\/002 (Health Research Ethics Committee, Stellenbosch University), and 605\/2020 (Faculty of Health Sciences Human Research Ethics Committee, University of Cape Town), following informed consent\/assent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The informed consent\/assent accounts for the publication of our research data are available upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}